ClinicalTrials.gg

Pfizer clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 4,072 studies whose lead sponsor is Pfizer or one of 15 companies grouped under it. 150 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 16 registry names, not the registry’s. See them and correct one ↓

Compare Pfizer with Hoffmann-La Roche and Merck →

Pipeline: 91 programs

Each counted once: 81 with a study Pfizer leads registered in the last two years, 10 more from Pfizer's own pipeline.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)
  • Named by Pfizer only (no registered study yet; not in the 91)

The 5 of 31 with the most live studies.

Program
berobenatidePhase 3 · Pfizer: Phase 3 · 17 live · Obesity · primary completion Jan 2027☆ Track
tivunatamigPhase 3 · Pfizer: Phase 3 · 10 live · Endometrial Neoplasms · primary completion Oct 2027☆ Track
tilrekimigPhase 3 · Pfizer: Phase 3 · 9 live · Dermatitis, Atopic · primary completion Feb 2027☆ Track
ritlecitinibPhase 3 · 8 live · Alopecia Areata · primary completion Dec 2026☆ Track
abrysvoPhase 3 · 7 live · Respiratory Tract Infections · primary completion Jan 2027☆ Track

26 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Pfizer’s own registered studies; “Pfizer says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

2 of Pfizer’s programs have a dated deal behind them: 2 brought in. Each from the companies’ own releases and filings, linked; the registry does not record them.

Brought in 2

What it is testing

The drugs Pfizer’s studies test, most open studies first — 537 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 537; every drug is on its own page, and each page lists its sponsors.

Coming up

91 of Pfizer’s studies under way reach primary completion within a year, 22 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 3N’26
  2. 16D
  3. 7J’27
  4. 9F
  5. 12M
  6. 6A
  7. 4M
  8. 5J
  9. 5J
  10. 7A
  11. 5S
  12. 8O
  13. 4N

The 12 nearest

Show 7 more

Add all 91 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

Newly registered19

Show 14 more

All 4,072 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1504%Recruiting 127 · Not yet recruiting 23
  • Under way, not recruiting1133%
  • Completed3,10276%
  • Stopped early68117%Terminated 562 · Withdrawn 119
  • Status unknown or other261%No longer available 16 · Available 5 · Approved for marketing 5

Phase

Where

Over the years

  1. 07
  2. 08
  3. 30809
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 10926

By the year each study started; 802 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Pfizer.

  • Pfizer
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3,337 studies
  • Wyeth is now a wholly owned subsidiary of Pfizer
    Acquired — became part of Pfizer, Oct 15, 2009 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    484 studies →
  • Seagen Inc.
    Acquired — became part of Pfizer, Dec 14, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    88 studies →
  • Seagen, a wholly owned subsidiary of Pfizer
    Acquired — became part of Pfizer, Dec 14, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    30 studies →
  • Hospira, now a wholly owned subsidiary of Pfizer
    Acquired — became part of Pfizer, Sep 3, 2015 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    28 studies →
  • Array Biopharma, now a wholly owned subsidiary of Pfizer
    Acquired — became part of Pfizer, Jul 30, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    25 studies →
  • Arena Pharmaceuticals
    Acquired — became part of Pfizer, Mar 11, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    17 studies →
  • Medivation, Inc.
    Acquired — became part of Pfizer, Sep 28, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    14 studies →
  • Cascadian Therapeutics Inc.
    Acquired — became part of Pfizer, Dec 14, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    12 studies →
  • Pharmacia and Upjohn
    Acquired — became part of Pfizer, Apr 16, 2003 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →
  • Global Blood Therapeutics
    Acquired — became part of Pfizer, Oct 5, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • Pharmacia
    Acquired — became part of Pfizer, Apr 16, 2003 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • Array BioPharma
    Acquired — became part of Pfizer, Jul 30, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Wyeth-Lederle Vaccines
    Acquired — became part of Pfizer, Oct 15, 2009 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Pfizer Pharmaceuticals Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Metsera, a wholly owned subsidiary of Pfizer
    Acquired — became part of Pfizer, Nov 13, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Pfizer leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 120 areas
Lymphoma40Prostatic Neoplasms39Hematologic Diseases37Osteoarthritis37Ovarian Neoplasms37Renal Insufficiency37Schizophrenia35Diabetes Mellitus34Hemophilia B33Spondylitis, Ankylosing33Anemia, Sickle Cell32Leukemia, Myeloid, Acute32Depression31Squamous Cell Carcinoma of Head and Neck30Arthritis29Lymphoma, Non-Hodgkin29Urinary Bladder, Overactive29Arthritis, Psoriatic28Bacterial Infections28Carcinoma27Stomach Neoplasms27Hyperlipidemias26Infections26Eczema25Asthma24Lymphoma, Large B-Cell, Diffuse24Pancreatic Neoplasms24Urinary Bladder Neoplasms24Respiratory Tract Infections23Hodgkin Disease22Lymphoma, Follicular22Pneumonia22Pulmonary Disease, Chronic Obstructive22Kidney Neoplasms21Encephalitis, Tick-Borne19Leukemia19Triple Negative Breast Neoplasms18Alopecia Areata17Chronic Pain17Colonic Neoplasms17Crohn Disease17Dwarfism, Pituitary17Hypercholesterolemia17Osteoarthritis, Knee17Uterine Cervical Neoplasms17Huntington Disease16Meningitis16Non-alcoholic Fatty Liver Disease16AIDS-Related Opportunistic Infections15Candidemia15Candidiasis15Hypertension15Inflammatory Bowel Diseases15Influenza, Human15Lymphoma, B-Cell15Lymphoma, Large-Cell, Anaplastic15Parkinson Disease15Carcinoma, Transitional Cell14Community-Acquired Pneumonia14Hepatitis C14Leukemia, Myelogenous, Chronic, BCR-ABL Positive14Macular Degeneration14Skin Diseases14Atrial Fibrillation13Endometrial Neoplasms13Generalized Anxiety Disorder13Myelodysplastic Syndromes13Osteoporosis13Respiratory Syncytial Virus Infections13Carcinoma, Hepatocellular12Esophageal Neoplasms12Fibromyalgia12Head and Neck Neoplasms12Intraabdominal Infections12Mycobacterium avium-intracellulare Infection12Neoplasms, Plasma Cell12Small Cell Lung Carcinoma12Stroke12AIDS-Related Complex11Healthcare-Associated Pneumonia11Hemorrhage11Meningitis, Cryptococcal11Metabolic Diseases11Onychomycosis11Precursor Cell Lymphoblastic Leukemia-Lymphoma11Pulmonary Arterial Hypertension11Arthritis, Juvenile10Aspergillosis10Diabetic Neuropathies10Gastroesophageal Reflux10Gram-Positive Bacterial Infections10Kidney Failure, Chronic10Malaria, Falciparum10Meningitis, Meningococcal10Pain, Postoperative10Rectal Neoplasms10

Studies

Recruiting first, then most recently updated. Showing 50 of 4,072. Browse all 4,072 →